VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH
SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that it intends to file on Tuesday, Nov. 12th, a Registration Statement with the Securities and Exchange Commission relating to a public offering by the company of 2 million shares of its common stock.
Of the shares to be offered for sale, 1.6 million shares will be offered in the United States, and 400,000 shares will be offered in a concurrent international offering outside the United States. Vertex Pharmaceuticals will grant to the underwriters in the U.S. offering an option to purchase up to 300,000 shares of common stock solely to cover over-allotments, if any.
/CONTACT: Richard Aldrich, vice president of Vertex, 617-576-3111; or Robert Gottlieb of Feinstein Partners, 617-577-8110, for Vertex/
(VRTX) CO: Vertex Pharmaceuticals Inc. ST: Massachusetts IN: MTC SU: DD-KM -- NE009 -- 3142 11/11/91 16:10 EST